LLY Eli Lilly and Company | US5324571083
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 98.734.815.490 | 85.394.920.560 | 15.62% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | 44,87 | 34,53 | 29.94% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 26 | 27 | 3.70% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |